An international panel of multidisciplinary experts convened to develop recommendations
for managing patients with colorectal cancer (CRC) and synchronous liver metastases …

Colorectal cancer liver metastases (CRLM) represent most of the causes of death in patients
with colorectal cancer. Surgical resection is the only treatment that can provide the …

Background RAS mutations have been reported to be a potential prognostic factor in
patients with colorectal liver metastases (CLM). However, the impact of RAS mutations on …

Purpose To evaluate the diagnostic performance of combined positron emission
tomography (PET) and magnetic resonace (MR) imaging (hereafter, PET/MR imaging) in the …

Background The role of 18-fluorodeoxyglucose positron emission tomography CT (18 FDG
PET/CT), as a prognostic factor for survival in colorectal cancer patients with liver …

The management of metastatic colon and rectal cancer has undergone significant evolution
over the last few decades. Due to advancements in chemotherapy, surgical techniques, and …

Background The assessment of colorectal liver metastases (CRLM) after treatment with
chemotherapy is challenging due to morphological and/or functional change without …

OBJECTIVE. The purpose of the present study is to evaluate Response Evaluation Criteria
in Solid Tumors (RECIST) version 1.1, tumor attenuation criteria, Choi criteria, and European …

Colorectal cancer (CRC) represents one of the leading causes of tumor-related deaths
worldwide. Among the various tools at physicians' disposal for the diagnostic management …

Purpose To evaluate the prognostic value of 18 F-fluorodeoxyglucose positron emission
tomography (FDG PET) with quantitative analysis using metabolic parameters in metastatic …